Effect of synthetic osteogenic growth peptide on hematopoiesis in normal mice and assay of its hematological activity in vitro

陈红红,施德源,邵云潮,罗伟华,陈统一,崔大敷,程文英

DOI: https://doi.org/10.3321/j.issn:1001-1978.2003.01.025

2003-01-01

Abstract:AIM: To investigate the stimulatory effects of synthetic osteogenic growth peptide (sOGP) on hematopoiesis in normal mice and proliferation of human hematopoietic progenitor cells. METHODS: sOGP(1,5,25 nmol · kg-1 d ·-1 were administered sc to mice daily for fourteen consecutive days. rhG-CSF was used as positive control. Bone marrow nucleated cells and peripheral blood cell counts were assayed. The differential cell counts in femoral bone marrow was evaluated. Colony-forming tests were performed in bone marrow cells from normal mice and man in vitro. RESULTS: The blood and bone marrow cellularity in normal mice were significantly enhanced, granulocytopoiesis being dominant. When sOGP was injected at the dose of 5,25 nmol · kg-1 d ·-1 respectively. The colony-forming-unit-granulocyte(CFU-G) in murine and human bone marrow in vitro was significantly increased by 1 × 10-14 ∼ 1 × 10-5 mol · L-1 sOGP, comparable to that found in G-CSF treated ones in similar concentration. CONCLUSION: sOGP may possess a central role of hematopoiesis, and a possible role on enhancing the restoration of bone marrow and blood cellularity after radio- and/or chemotherapy.